Fairfield, CT, United States of America

Ajay Shrivastava


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 7(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ajay Shrivastava: Innovator in Tyrosine Kinase Receptor Research

Introduction: Ajay Shrivastava, located in Fairfield, CT, is a notable inventor recognized for his contributions to the field of biochemistry, particularly in the study of tyrosine kinase receptors. With one patent to his name, Shrivastava has made significant advancements in understanding the interactions between ligands and their respective receptors, paving the way for potential therapeutic applications.

Latest Patents: His patent, titled "Assay for ligands to tyrosine kinase receptors," presents a novel screening method for polypeptide ligands that bind specifically to the Tyro-10 (DDR-2) or NEP (DDR-1) receptors. This invention not only identifies molecules that can compete with collagen for binding but also allows for the detection of their interactions with these critical receptors. The implications of this invention are vast, as it offers insights into promoting cell growth and differentiation, thereby influencing various cellular phenotypes.

Career Highlights: Ajay Shrivastava currently works at Regeneron Pharmaceuticals, Inc., a leading biotechnology company dedicated to developing innovative medicines for serious diseases. His role at Regeneron highlights his commitment to advancing scientific research and innovation within the biotechnology sector.

Collaborations: Throughout his career, Shrivastava has collaborated with esteemed colleagues, including Czeslaw Radziejewski and George D. Yancopoulos. These collaborations reflect a teamwork-oriented approach, fostering an environment where innovative ideas can thrive and lead to successful research outcomes.

Conclusion: Ajay Shrivastava's work in the arena of tyrosine kinase receptors showcases his dedication to biomedical innovation. His patent offers significant potential for future research and applications in cellular therapy, and his ongoing collaborations with industry leaders further amplify the impact of his contributions. Shrivastava exemplifies the spirit of innovation that drives advancements in science and medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…